Diferric Complex Research Articles

Electrocatalytic Interconversions of CO2 and Formate on a Versatile Iron-Thiolate Platform.

Exploring bidirectional CO2/HCO2- catalysis holds significant potential in constructing integrated (photo)electrochemical formate fuel cells for energy storage and applications. Herein, we report selective CO2/HCO2- electrochemical interconversion by exploiting the flexible coordination modes and rich redox properties of a versatile iron-thiolate platform, Cp*Fe(II)L (L = 1,2-Ph2PC6H4S-). Upon oxidation, this iron complex undergoes formate binding to generate a diferric formate complex, [(L-)2Fe(III)(μ-HCO2)Fe(III)]+, which exhibits remarkable electrocatalytic performance for the HCO2--to-CO2 transformation with a maximum turnover frequency (TOFmax) ∼103 s-1 and a Faraday efficiency (FE) ∼92(±4)%. Conversely, this iron system also allows for reduction at -1.85 V (vs Fc+/0) and exhibits an impressive FE ∼93 (±3)% for the CO2-to-HCO2- conversion. Mechanism studies revealed that the HCO2--to-CO2 electrocatalysis passes through dicationic [(L2)-•Fe(III)(μ-HCO2)Fe(III)]2+ generated by unconventional oxidation of the diferric formate species taking place at ligand L, while the CO2-to-HCO2- reduction involves a critical intermediate of [Fe(II)-H]- that was independently synthesized and structurally characterized.

Reconstitution of the Final Steps in the Biosynthesis of Valanimycin Reveals the Origin of Its Characteristic Azoxy Moiety

AbstractValanimycin is an azoxy‐containing natural product isolated from the fermentation broth of Streptomyces viridifaciens MG456‐hF10. While the biosynthesis of valanimycin has been partially characterized, how the azoxy group is constructed remains obscure. Herein, the membrane protein VlmO and the putative hydrazine synthetase ForJ from the formycin biosynthetic pathway are demonstrated to catalyze N−N bond formation converting O‐(l‐seryl)‐isobutyl hydroxylamine into N‐(isobutylamino)‐l‐serine. Subsequent installation of the azoxy group is shown to be catalyzed by the non‐heme diiron enzyme VlmB in a reaction in which the N−N single bond in the VlmO/ForJ product is oxidized by four electrons to yield the azoxy group. The catalytic cycle of VlmB appears to begin with a resting μ‐oxo diferric complex in VlmB, as supported by Mössbauer spectroscopy. This study also identifies N‐(isobutylamino)‐d‐serine as an alternative substrate for VlmB leading to two azoxy regioisomers. The reactions catalyzed by the kinase VlmJ and the lyase VlmK during the final steps of valanimycin biosynthesis are established as well. The biosynthesis of valanimycin was thus fully reconstituted in vitro using the enzymes VlmO/ForJ, VlmB, VlmJ and VlmK. Importantly, the VlmB‐catalyzed reaction represents the first example of enzyme‐catalyzed azoxy formation and is expected to proceed by an atypical mechanism.

Reconstitution of the Final Steps in the Biosynthesis of Valanimycin Reveals the Origin of Its Characteristic Azoxy Moiety.

Valanimycin is an azoxy-containing natural product isolated from the fermentation broth of Streptomyces viridifaciens MG456-hF10. While the biosynthesis of valanimycin has been partially characterized, how the azoxy group is constructed remains obscure. Herein, the membrane protein VlmO and the putative hydrazine synthetase ForJ from the formycin biosynthetic pathway are demonstrated to catalyze N-N bond formation converting O-(l-seryl)-isobutyl hydroxylamine into N-(isobutylamino)-l-serine. Subsequent installation of the azoxy group is shown to be catalyzed by the non-heme diiron enzyme VlmB in a reaction in which the N-N single bond in the VlmO/ForJ product is oxidized by four electrons to yield the azoxy group. The catalytic cycle of VlmB appears to begin with a resting μ-oxo diferric complex in VlmB, as supported by Mössbauer spectroscopy. This study also identifies N-(isobutylamino)-d-serine as an alternative substrate for VlmB leading to two azoxy regioisomers. The reactions catalyzed by the kinase VlmJ and the lyase VlmK during the final steps of valanimycin biosynthesis are established as well. The biosynthesis of valanimycin was thus fully reconstituted in vitro using the enzymes VlmO/ForJ, VlmB, VlmJ and VlmK. Importantly, the VlmB-catalyzed reaction represents the first example of enzyme-catalyzed azoxy formation and is expected to proceed by an atypical mechanism.

Reduction of Nitric Oxide to Nitrous Oxide in Flavodiiron Proteins: Catalytic Mechanism and Plausible Intermediates

The flavin dependent nonheme diiron proteins comprise a family of enzymes, which can act as scavengers for both molecular oxygen and nitric oxide. The reduction of nitric oxide to nitrous oxide and water in flavodiiron proteins (FDPs) has been studied both experimentally and computationally, but the reaction mechanism is far from well understood. From experiments, it is known that two NO molecules can bind to the reduced active site, forming an observable diferrous dinitrosyl complex. A main question has been whether nitrous oxide can be formed directly from the diferrous dinitrosyl complex or if further reduction and/or protonation is needed to make this step feasible. Experiments have shown that nitrous oxide can be formed in a deflavinated form of the enzyme, indicating that further reduction is not needed. In the present study, hybrid density functional theory calculations are performed on a cluster model of the Thermotoga maritima FDP active site. We show that nitric oxide can be reduced to nitrous oxide and water using a direct coupling mechanism, i.e., without further additions to the reduced active site. The diferrous dinitrosyl complex can form an unstable N–N bridging hyponitrite intermediate, which can rotate into an N–O bond bridging hyponitrite with a low barrier. From this intermediate, the N–O bond cleavage leading to release of nitrous oxide is energetically feasible. An energy profile for the entire catalytic cycle of such a direct coupling mechanism is presented, and it is shown that the suggested mechanism agrees with data on FDP variants. Finally, an energy profile for the entire process starting with the fully reduced enzyme turning over four NO equivalents is constructed. This energy profile suggests explanations to experimentally observed states, such as the dihydroxyl form of the fully oxidized diferric state, and the difference with respect to returning to the original oxidized state after NO reduction between the flavinated and the deflavinated form of the enzyme.

Direct and remote control of electronic structures and redox potentials in μ-oxo diferric complexes.

Non-heme diiron enzymes activate O2 for the oxidation of substrates in the form of peroxo FeIII2 or high-valent FeIV2 intermediates. We have developed a dinucleating bis(tetradentate) ligand system that stabilizes peroxo and hydroperoxo FeIII2 complexes with terminal 6-methylpyridine donors, while the peroxo FeIII2 intermediate is reactive with terminal pyridine donors presumably via conversion to a fluent high-valent FeIV2 intermediate. We present here a derivative with electron-donating methoxy substituents at the pyridine donors and its diferric complexes with an {FeIIIX(μ-O)FeIIIX} (X- = Cl-, OAc-, and OH-) or an {FeIII(μ-O)(μ-OAc)FeIII} core. The complex-induced oxidation of EtOH with H2O2 provides μ-OAc-, and in acetone, the complex with mixed OH-/OAc- exogenous donors is obtained. Both reactivities indicate a reactive fluent peroxo FeIII2 intermediate. The coupling constant J and the LMCT transitions are insensitive to the nature of the directly bound ligands X- and reflect mainly the electronic structure of the central {FeIII(μ-O)FeIII} core, while Mössbauer spectroscopy and d-d transitions probe the local FeIII sites. The remote methoxy substituents decrease the potential for the oxidation to FeIV by ∼100 mV, while directly bound OH- in {FeIII(OH)(μ-O)FeIII(OH)} with a short 1.91 Å FeIII-OOH bond decreases the potential by 590 mV compared to {FeIII(OAc)(μ-O)FeIII(OAc)} with a 2.01 Å FeIII-OOAc bond. Interestingly, this FeIII-OH bond is even shorter (1.87 Å) in the mixed OH-/OAc- complex but the potential is the mean value of the potentials of the OH-/OH- and OAc-/OAc- complexes, thus reflecting the electron density of the central {FeIII(μ-O)FeIII} core and not of the local FeIII-OH unit.

A Reactive, Photogenerated High-Spin (S = 2) FeIV(O) Complex via O2 Activation.

Addition of dioxygen at low temperature to the non-heme ferrous complex FeII(Me3TACN)((OSiPh2)2O) (1) in 2-MeTHF produces a peroxo-bridged diferric complex Fe2III(μ-O2)(Me3TACN)2((OSiPh2)2O)2 (2), which was characterized by UV-vis, resonance Raman, and variable field Mössbauer spectroscopies. Illumination of a frozen solution of 2 in THF with white light leads to homolytic O-O bond cleavage and generation of a FeIV(O) complex 4 (ν(Fe=O) = 818 cm-1; δ = 0.22 mm s-1, ΔEQ = 0.23 mm s-1). Variable field Mössbauer spectroscopy measurements show that 4 is a rare example of a high-spin S = 2 FeIV(O) complex and the first synthetic example to be generated directly from O2. Complex 4 is highly reactive, as expected for a high-spin ferryl, and decays rapidly in fluid solution at cryogenic temperatures. This decay process in 2-MeTHF involves C-H cleavage of the solvent. However, the controlled photolysis of 2 in situ with visible light and excess phenol substrate leads to competitive phenol oxidation, via the proposed transient generation of 4 as the active oxidant.

A Dinucleating Ligand System with Varying Terminal Donors to Mimic Diiron Active Sites

AbstractTo mimic dinuclear active sites of metalloproteins, we have developed a dinucleating ligand system consisting of two tetradentate tripodal ligand compartments with varying terminal donors (carboxylates, phenolates, and pyridines). These ligands provide access to a series of μ‐oxo‐bridged diferric complexes. The spectroscopic study allows to investigate the molecular structures even in solution, e. g. depending on protonation/deprotonation of coordinated OH− and H2O ligands or to observe a reversible pH‐dependent carboxylate‐shift between terminal and bridging binding mode. The electrochemical behavior is strongly influenced by the exogenous ligands, e. g. OH− facilitates oxidation to FeIV by 690 mV relative to Cl−. Using the terminal carboxylates and a {FeIII(μ‐O)2FeIII} core even allows oxidation with O2 to a high‐valent species with FeIV (S=2). The implications of this study for further generation of high‐valent or peroxo species and their utilization in catalysis is discussed.

High‐Spin and Low‐Spin Perferryl Intermediates in Fe(PDP)‐Catalyzed Epoxidations

AbstractTwo bioinspired hydroxo‐bridged diferric complexes 6 and 7 with N4‐donor ligands of the PDP type (PDP=N,N′‐bis(pyridin‐2‐ylmethyl)‐2,2′‐bipyrrolidine), differing by substituents at the pyridine rings (4‐NMe2 in 7 vs. 3,5‐Me2‐4‐OMe in 6), efficiently catalyze the enantioselective alkene epoxidation with H2O2 and peracetic acid in the presence of a carboxylic acid additive (up to 99 catalyst turnover numbers, TON, toward epoxide, up to 94 % ee). Catalyst systems based on complex 7 display the high‐spin perferryl intermediate 7 aAA (S=3/2, g1, g2=3.69, g3=1.96), whereas catalyst systems based on complex 6 exhibit the low‐spin perferryl intermediate 6 aAA (S=1/2, g1=2.07, g2=2.01, g3=1.96). The S=3/2 and the S=1/2 intermediates directly react with cyclohexene and cyclohexane at low temperatures (−40 °C and −85 °C, respectively). The catalyst systems, exhibiting less reactive intermediate 7 aAA, demonstrate higher enantioselectivity (% ee) in the epoxidation of chalcone. The origin of the unprecedented high‐spin state of the perferryl intermediate is discussed.

Diiron oxo reactivity in a weak-field environment.

Concomitant deprotonation and metalation of a dinucleating cofacial Pacman dipyrrin ligand platform tBudmxH2 with Fe2(Mes)4 results in formation of a diiron complex ( tBudmx)Fe2(Mes)2. Treatment of ( tBudmx)Fe2(Mes)2 with one equivalent of water yields the diiron μ-oxo complex ( tBudmx)Fe2(μ-O) and free mesitylene. A two-electron oxidation of ( tBudmx)Fe2(μ-O) gives rise to the diferric complex ( tBudmx)Fe2(μ-O)Cl2, and one-electron reduction from this FeIIIFeIII state allows for isolation of a mixed-valent species [Cp2Co][( tBudmx)Fe2(μ-O)Cl2]. Both ( tBudmx)Fe2(μ-O) and [Cp2Co][( tBudmx)Fe2(μ-O)Cl2] exhibit basic character at the bridging oxygen atom and can be protonated using weak acids to form bridging diferrous hydroxide species. The basicity of the diferrous oxo ( tBudmx)Fe2(μ-O) is quantified through studies of the pK a of its conjugate acid, [( tBudmx)Fe2(μ-OH)]+, which is determined to be 15.3(6); interestingly, upon coordination of neutral solvent ligands to yield ( tBudmx)Fe2(μ-O)(thf)2, the basicity is increased as observed through an increase in the pK a of the conjugate acid [( tBudmx)Fe2(μ-OH)(thf)2]+ to 26.8(6). In contrast, attempts to synthesize a diferric bridging hydroxide by two-electron oxidation of [( tBudmx)Fe2(μ-OH)(thf)2]+ resulted in isolation of ( tBudmx)Fe2(μ-O)Cl2 with concomitant loss of a proton, consistent with the pK a of the conjugate acid [( tBudmx)Fe2(μ-OH)Cl2]+ determined computationally to be -1.8(6). The foregoing results highlight the intricate interplay between oxidation state and reactivity in diiron μ-oxo units.

Effect of Oxidation and Protonation States on [2Fe-2S] Cluster Nitrosylation Giving {Fe(NO)2}9 Dinitrosyl Iron Complexes (DNICs).

The nitrosylation of biological Fe/S clusters to give protein-bound dinitrosyl iron complexes (DNICs) is physiologically important. Biomimetic studies on the reaction of synthetic [2Fe-2S] clusters with NO have so far been limited to diferric model complexes. This work now compares the nitrosylation of [2Fe-2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis(benzimidazolate) capping ligands in their diferric (12- and 22-) and mixed-valent (FeIIFeIII, 13-, and 23-) forms. Furthermore, the effect of protonation of the imidazole part of the SN ligand has been probed on both the nitrosylation reaction and properties of the resulting DNIC. The reaction of 12- and 22- with 4 equiv NO yields the new anionic {Fe(NO)2}9 DNICs 3- and 4-, respectively, which have been comprehensively characterized, including X-ray crystallography of their PPN+ salts. Nitrosylation of mixed-valent [2Fe-2S] clusters 13- and 23- first leads to slow oxidation to the corresponding diferric congeners, followed by core degradation and DNIC formation. In the case of 23-, a second diferric intermediate very similar to 22- is detected by UV-vis spectroscopy, but could not be further identified. Nitrosylation of 1H2 gives the neutral, N-protonated DNIC 3H, and acid/base titrations show that interconversion between 3- and 3H is reversible. Peripheral ligand protonation leads to a blue shift of the NO stretching vibrations by about 23 cm-1 and a significant shift of the reduction potential to less negative values (Δ E1/2 = 0.26 V), but no effect on 57Fe Mössbauer parameters is observed. Density functional theory calculations based on the structure of 3- indicate that the electronic ground-state properties of 3- and 3H are similar, although the NO(π*) → Fe 3d π-donation is slightly increased and π-backbonding is slightly decreased upon protonation. As a result, protonation has a significant effect on the NO stretching frequencies, but only minor effects on the Fe-(NO)2 modes. This is confirmed by nuclear inelastic scattering of 3- and 3H, which shows no clear influence of protonation on the energy of the Fe-(NO)2 bending and stretching modes occurring in the range 400-600 cm-1, but characteristic changes below 350 cm-1 that reflect perturbation of free rotary motion of the thiophenolate and benzimidazole ring systems of the capping ligand after N-protonation. These findings add to the understanding of [2Fe-2S] cluster nitrosylation and will help to identify DNICs resulting from the reaction of NO with Fe/S cofactors featuring alternative, proton-responsive histidine ligands such as the Rieske and mitoNEET [2Fe-2S] clusters.

Reactivity Differences for the Oxidation of FeIIFeII to FeIII(µ‐O)FeIII Complexes Caused by Pyridyl versus 6‐Methyl‐Pyridyl Ligands

The dinucleating bis(tetradentate) ligand susan [= 4,7‐dimethyl‐1,1,10,10‐tetra(2‐pyridylmethyl)‐1,4,7,10‐tetraazadecane] reacts with [Fe(OH2)6](BF4)2 to the complex [(susan){FeIIIF(µ‐O)FeIIIF}](BF4)2. In contrast, the reaction of the ligand derivative susan6‐Me with 6‐methylpyridyl instead of pyridyl donors with [Fe(OH2)6](BF4)2 results in the complexes [(susanMe){FeII(µ‐F)2FeII}](BF4)2 and [(susanMe){FeIIF(µ‐F)FeIIIF}](BF4)2. The synthesis of the µ‐oxo diferric complex [(susan6‐Me){FeIIIF(µ‐O)FeIIIF}]2+ requires the addition of H2O2 as oxidant. The best synthesis is the H2O2 oxidation of the new diferrous precursor [(susan6‐Me){FeII(µ‐F)2FeII}](ClO4)2. The introduction of the 6‐methylpyridine donors results in an elongation of the Fe–Npy bonds. The resulting lower electron donation is not compensated by the µ‐oxo bond but slightly by the Fe–Namine bonds. These structural changes are correlated with the νas(FeOFe) stretching mode, a smaller Mössbauer quadrupole splitting, a smaller ligand field splitting, a weaker antiferromagnetic exchange, and an anodic shift of the redox potentials. This destabilization of the ferric state correlates with the different reactivity of the diferrous precursors to the µ‐oxo diferric complexes: air for susan and H2O2 for for susan6‐Me. Structural analysis indicates a steric repulsion of the 6‐methyl group with the fluorido ligand in cis‐position as origin for the longer Fe–Npy bonds, which seems to be a general phenomenon.

Mechanism of the Dinuclear Iron Enzyme p‐Aminobenzoate N‐oxygenase from Density Functional Calculations

AbstractAurF is a diiron enzyme that utilizes two dioxygen molecules as the oxidant to catalyze the oxidation of p‐aminobenzoate to p‐nitrobenzoate. Density functional calculations were performed to elucidate the reaction mechanism of this enzyme. Two different models were considered, with the oxygenated intermediate being a diferric peroxo species or a diferric hydroperoxo species. The calculations strongly favor the model with a diferric peroxo species and support the mechanism proposed by Bollinger and co‐workers. The reaction starts with the binding of a dioxygen molecule to the diferrous center to generate a diferric peroxide complex. This is followed by the cleavage of the O−O bond, concertedly with the formation of the first N−O bond, which has a barrier of only 9.2 kcal/mol. Subsequently, the first‐shell ligand Glu227 abstracts a proton from the substrate. After the delivery of two electrons from the external reductant and two protons from solution, a water molecule and the experimentally suggested intermediate p‐hydroxylaminobenzoate are produced and the diferrous center is regenerated. The oxidation of the p‐hydroxylaminobenzoate intermediate requires the binding of a second dioxygen molecule to the diferrous center to generate the diferric peroxide complex. Similarly to the oxidation of p‐aminobenzoate, the O−O bond cleavage and the formation of the second N−O bond take place in a concerted step. The p‐nitrobenzoate product is formed after the release of two protons and two electrons from the substrate. The model with a hydroperoxo species gave a much high barrier of 28.7 kcal/mol for the substrate oxidation due to the large energy penalty for the generation of the active hydroperoxo species.

Non-Heme Diiron Model Complexes Can Mediate Direct NO Reduction: Mechanistic Insight into Flavodiiron NO Reductases.

Flavodiiron nitric oxide reductases (FNORs), a common enzyme family found in various types of pathogenic bacteria, are capable of reducing nitric oxide (NO) to nitrous oxide (N2O) as a protective detoxification mechanism. Utilization of FNORs in pathogenic bacteria helps them survive and proliferate in the human body, thus causing chronic infections. In this paper, we present a new diiron model complex, [Fe2((Py2PhO2)MP)(OPr)2](OTf), with bridging propionate ligands (OPr-) that is capable of directly reducing NO to N2O in quantitative yield without the need to (super)reduce the complex. We first prepared the diferric precursor and characterized it by UV-vis, IR, NMR and Mössbauer spectroscopies, cyclic voltammetry, and mass spectrometry. This complex can then conveniently be reduced to the diferrous complex using CoCp2. Even though this diferrous complex is highly reactive, we have successfully isolated and characterized this species using X-ray crystallography and various spectroscopic techniques. Most importantly, upon reacting this diferrous complex with NO gas, we observe quantitative formation of N2O via IR gas headspace analysis, the first demonstration of direct NO reduction by a non-heme diiron model complex. This finding directly supports recent mechanistic proposals for FNORs.

Synthesis and Characterization of a μ‐Oxo‐Bridged Diferric Complex: An Attempt to Influence the Configuration by Changing the Spacer

The μ‐oxo‐bridged diferric complex [(susanPr){FeIIICl(μ‐O)FeIIICl}](ClO4)2 was synthesized and characterized by single‐crystal X‐ray diffraction, elemental analysis, FT‐IR, UV/Vis/NIR, and Mössbauer spectroscopies as well as magnetic and electrochemical measurements. The properties are compared to the corresponding values for the complex [(susan){FeIIICl(μ‐O)FeIIICl}](ClO4)2, which exhibits a central ethylene spacer, whereas [(susanPr){FeIIICl(μ‐O)FeIIICl}](ClO4)2 has a propylene spacer. Both complexes exhibit a trans configuration of the two terminal chloride ligands. This configuration induces more steric demand in the case of the propylene spacer, which results in a rotation of the two octahedral units along the Fe–(μ‐O)–Fe axis and a tilting of the Fe–N bonds of the diamine spacer. The iron bond lengths are only slightly elongated by the steric demand of the propylene spacer, which is reflected by almost no change in the Mössbauer spectrum. However, the UV/Vis/NIR spectra show a stronger ligand field for [(susanPr){FeIIICl(μ‐O)FeIIICl}](ClO4)2. The slightly longer iron bond lengths result in less electron donation, which is reflected by an anodic shift of 120 mV for the oxidation of the complex. This comparison provides more information on the variation of the properties of the diferric complexes by slight changes in the second coordination sphere.

Variation of the Molecular and Electronic Structures of μ‐Oxo Diferric Complexes with the Bridging Motive

The complexes [(susan){FeIII(OAc)(μ‐O)FeIII(OAc)}](ClO4)2, [(susan){FeIII(μ‐O)(μ‐OAc)FeIII}](ClO4)3, and [(susan){FeIII(μ‐O)(μ‐CO3)FeIII}](ClO4)2 (susan = 4,7‐dimethyl‐1,1,10,10‐tetra(2‐pyridylmethyl)‐1,4,7,10‐tetraazadecane) were synthesized and characterized. Prominent IR vibrations do not shift from the solid state to CH3CN solutions demonstrating dissolution without structural rearrangements or substitutions. The acetates in [(susan){FeIII(OAc)(μ‐O)FeIII(OAc)}]2+ are in a trans conformation resulting in a C2 symmetry of the central core and the overall complex. On the other hand, a second bridging ligand enforces a CS symmetry of the central core, which is incommensurable with the wrapping of the ligand around the central core resulting in only overall C1 symmetry. The Fe–OAc bonds are shorter for the terminal acetates (1.93 Å) than for the bridging acetate (1.97 and 2.07 Å). The bridging dianionic carbonate also results in shorter Fe–Ocarb bonds (1.91 and 1.97 Å). Mössbauer spectroscopy shows a lower quadrupole splitting for [(susan){FeIII(μ‐O)(μ‐CO3)FeIII}](ClO4)2 in line with the shorter and thus more covalent Fe–Ocarb bonds. UV/Vis/NIR spectra differ in the d–d and in the LMCT regions for the mono‐ and doubly‐bridged complexes. The electrochemical characterization shows variations for the potentials for oxidations and reductions. This variation is discussed in light of the difference in π‐donor interactions and the overall charge of the complexes.

Reversible Carboxylate Shift in a μ-Oxo Diferric Complex in Solution by Acid-/Base-Addition.

A reversible carboxylate shift has been observed in a μ-oxo diferric complex in solution by UV-vis-NIR and FTIR spectroscopy triggered by the addition of a base or an acid. A terminal acetate decoordinates upon the addition of a proton, resulting in a shift of the remaining terminal acetato to a μ-η1:η1 bridge. The addition of a base restores the original structure containing only terminal acetates. The implications for metalloenzymes with carboxylate-bridged nonheme diiron active sites are discussed.

Reagent‐Regulated Oxidative O‐Demethylation of a Ferrous Complex Stabilized by a Tetradentate N Ligand with a Methoxyphenyl Substituent

A ferrous complex FeIILOMeCl2, 1, where LOMe is 2‐methoxy‐N,N‐bis(pyridin‐2‐ylmethyl) aniline, has been synthesized and studies on its structure, spectral properties, and reactivity have been carried out. The complex has rich spectral properties and shows a well‐defined paramagnetic 1H NMR spectrum with sharp and hyperfine shifted signals, which were assigned with the help of a combination of 1H–1H COSY and T1 and T2 relaxation time measurements. Though stable to air, complex 1 underwent oxidation in the presence of AgClO4, which resulted in the formation of a symmetric diferric oxo complex [(LOMeFeIIICl)2O](ClO4)2, 2. However, on reaction with strong oxidants such as tBuOOH, complex 1 yielded a mixture of an unsymmetric diferric oxo complex LOMeFeIIIClOFeIIICl3, 3, and a mononuclear ferric complex LO–FeIIICl2, 4, with a modified phenoxide ligand LO–, which is formed as a result of the demethylation of LOMe during oxidation. The factors affecting O‐demethylation were studied and a possible mechanistic pathway involving a high‐valent iron‐oxo species is proposed.

The Semireduced Mechanism for Nitric Oxide Reduction by Non-Heme Diiron Complexes: Modeling Flavodiiron Nitric Oxide Reductases.

Flavodiiron nitric oxide reductases (FNORs) are a subclass of flavodiiron proteins (FDPs) capable of preferential binding and subsequent reduction of NO to N2O. FNORs are found in certain pathogenic bacteria, equipping them with resistance to nitrosative stress, generated as a part of the immune defense in humans, and allowing them to proliferate. Here, we report the spectroscopic characterization and detailed reactivity studies of the diiron dinitrosyl model complex [Fe2(BPMP)(OPr)(NO)2](OTf)2 for the FNOR active site that is capable of reducing NO to N2O [Zheng et al., J. Am. Chem. Soc. 2013, 135, 4902-4905]. Using UV-vis spectroscopy, cyclic voltammetry, and spectro-electrochemistry, we show that one reductive equivalent is in fact sufficient for the quantitative generation of N2O, following a semireduced reaction mechanism. This reaction is very efficient and produces N2O with a first-order rate constant k > 102 s-1. Further isotope labeling studies confirm an intramolecular N-N coupling mechanism, consistent with the rapid time scale of the reduction and a very low barrier for N-N bond formation. Accordingly, the reaction proceeds at -80 °C, allowing for the direct observation of the mixed-valent product of the reaction. At higher temperatures, the initial reaction product is unstable and decays, ultimately generating the diferrous complex [Fe2(BPMP)(OPr)2](OTf) and an unidentified ferric product. These results combined offer deep insight into the mechanism of NO reduction by the relevant model complex [Fe2(BPMP)(OPr)(NO)2]2+ and provide direct evidence that the semireduced mechanism would constitute a highly efficient pathway to accomplish NO reduction to N2O in FNORs and in synthetic catalysts.

Hydrogen-Atom Transfer Oxidation with H2O2 Catalyzed by [FeII(1,2-bis(2,2'-bipyridyl-6-yl)ethane(H2O)2]2+: Likely Involvement of a (μ-Hydroxo)(μ-1,2-peroxo)diiron(III) Intermediate.

The iron(II) triflate complex (1) of 1,2-bis(2,2'-bipyridyl-6-yl)ethane, with two bipyridine moieties connected by an ethane bridge, was prepared. Addition of aqueous 30% H2O2 to an acetonitrile solution of 1 yielded 2, a green compound with λmax=710 nm. Moessbauer measurements on 2 showed a doublet with an isomer shift (δ) of 0.35 mm/s and a quadrupole splitting (ΔEQ) of 0.86 mm/s, indicative of an antiferromagnetically coupled diferric complex. Resonance Raman spectra showed peaks at 883, 556 and 451 cm-1 that downshifted to 832, 540 and 441 cm-1 when 1 was treated with H218O2. All the spectroscopic data support the initial formation of a (μ-hydroxo)(μ-1,2-peroxo)diiron(III) complex that oxidizes carbon-hydrogen bonds. At 0°C 2 reacted with cyclohexene to yield allylic oxidation products but not epoxide. Weak benzylic C-H bonds of alkylarenes were also oxidized. A plot of the logarithms of the second order rate constants versus the bond dissociation energies of the cleaved C-H bond showed an excellent linear correlation. Along with the observation that oxidation of the probe substrate 2,2-dimethyl-1-phenylpropan-1-ol yielded the corresponding ketone but no benzaldehyde, and the kinetic isotope effect, kH/kD , of 2.8 found for the oxidation of xanthene, the results support the hypothesis for a metal-based H-atom abstraction mechanism. Complex 2 is a rare example of a (μ-hydroxo)(μ-1,2-peroxo)diiron(III) complex that can elicit the oxidation of carbon-hydrogen bonds.

Solving Biology's Iron Chemistry Problem with Ferritin Protein Nanocages.

Ferritins reversibly synthesize iron-oxy(ferrihydrite) biominerals inside large, hollow protein nanocages (10-12 nm, ∼480 000 g/mol); the iron biominerals are metabolic iron concentrates for iron protein biosyntheses. Protein cages of 12- or 24-folded ferritin subunits (4-α-helix polypeptide bundles) self-assemble, experimentally. Ferritin biomineral structures differ among animals and plants or bacteria. The basic ferritin mineral structure is ferrihydrite (Fe2O3·H2O) with either low phosphate in the highly ordered animal ferritin biominerals, Fe/PO4 ∼ 8:1, or Fe/PO4 ∼ 1:1 in the more amorphous ferritin biominerals of plants and bacteria. While different ferritin environments, plant bacterial-like plastid organelles and animal cytoplasm, might explain ferritin biomineral differences, investigation is required. Currently, the physiological significance of plant-specific and animal-specific ferritin iron minerals is unknown. The iron content of ferritin in living tissues ranges from zero in "apoferritin" to as high as ∼4500 iron atoms. Ferritin biomineralization begins with the reaction of Fe(2+) with O2 at ferritin enzyme (Fe(2+)/O oxidoreductase) sites. The product of ferritin enzyme activity, diferric oxy complexes, is also the precursor of ferritin biomineral. Concentrations of Fe(3+) equivalent to 2.0 × 10(-1) M are maintained in ferritin solutions, contrasting with the Fe(3+) Ks ∼ 10(-18) M. Iron ions move into, through, and out of ferritin protein cages in structural subdomains containing conserved amino acids. Cage subdomains include (1) ion channels for Fe(2+) entry/exit, (2) enzyme (oxidoreductase) site for coupling Fe(2+) and O yielding diferric oxy biomineral precursors, and (3) ferric oxy nucleation channels, where diferric oxy products from up to three enzyme sites interact while moving toward the central, biomineral growth cavity (12 nm diameter) where ferric oxy species, now 48-mers, grow in ferric oxy biomineral. High ferritin protein cage symmetry (3-fold and 4-fold axes) and amino acid conservation coincide with function, shown by amino acid substitution effects. 3-Fold symmetry axes control Fe(2+) entry (enzyme catalysis of Fe(2+)/O2 oxidoreduction) and Fe(2+) exit (reductive ferritin mineral dissolution); 3-fold symmetry axes influence Fe(2+)exit from dissolved mineral; bacterial ferritins diverge slightly in Fe/O2 reaction mechanisms and intracage paths of iron-oxy complexes. Biosynthesis rates of ferritin protein change with Fe(2+) and O2 concentrations, dependent on DNA-binding, and heme binding protein, Bach 1. Increased cellular O2 indirectly stabilizes ferritin DNA/Bach 1 interactions. Heme, Fe-protoporphyrin IX, decreases ferritin DNA-Bach 1 binding, causing increased ferritin mRNA biosynthesis (transcription). Direct Fe(2+) binding to ferritin mRNA decreases binding of an inhibitory protein, IRP, causing increased ferritin mRNA translation (protein biosynthesis). Newly synthesized ferritin protein consumes Fe(2+) in biomineral, decreasing Fe(2)(+) and creating a regulatory feedback loop. Ferritin without iron is "apoferritin". Iron removal from ferritin, experimentally, uses biological reductants, for example, NADH + FMN, or chemical reductants, for example, thioglycolic acid, with Fe(2+) chelators; physiological mechanism(s) are murky. Clear, however, is the necessity of ferritin for terrestrial life by conferring oxidant protection (plants, animals, and bacteria), virulence (bacteria), and embryonic survival (mammals). Future studies of ferritin structure/function and Fe(2+)/O2 chemistry will lead to new ferritin uses in medicine, nutrition, and nanochemistry.